Sfoglia per AUTORE
MORABITO F
Collezione ASL Vercelli

  

Items : 5

Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomidedexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data. in Haematologica / Haematologica. 2025 Mar 6. doi: 10.3324/haematol.2025.287325.

2025
ASL Vercelli
AOU Città della Salute di Torino
AOU Novara

Gentile M; Tripepi G; Morabito F; Neri A; Musto P; Petrucci MT; Bolli N; Di Raimondo F; De Stefano V; Morè S; De Paoli L; Barilà G; Benvenuti P; Cotzia E; Mele A; Annibali O; Bertuglia G; Furlan A; Lombardo A; Maggi A; Antonioli E; Aquino S; Tarantini G; Vincelli ID; Farina F; Micozzi J; Roccotelli D; Quaresima M; Barbieri E; et alii...

Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials. in Haematologica / Haematologica. 2025 Apr 1;110(4):1028-1033. doi: 10.3324/haematol.2024.286658. Epub 2024 Nov 28.

2025
ASL Vercelli
AOU Città della Salute di Torino
AOU Novara

Morabito F; Musto P; Di Raimondo F; Petrucci MT; Neri A; Coscia M; Galli M; De Stefano V; Amico V; Di Renzo N; Quinto AM; Brunori M; Cotzia E; Pietrantuono G; Montefusco V; Gozzetti A; Neri S; Monachesi M; Maggi A; Zambello R; Lombardo A; Citro A; Uccello G; Roccotelli D; Amendola A; Califano C; Morè S; Rivolti E; Nappi D; et alii...

Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) As Salvage Therapy for Patients with Multiple Myeloma: Multicenter, Retrospective Clinical Experience with 262 Cases Outside of Controlled Clinical Trials in Blood

2024
ASL Vercelli

Martino EA; Derudas D; Rossi E; Terlizzi S; Reddiconto G; Stefanoni P; Micozzi J; Mangiacavalli S; Zamagni E; Offidani M; Furlan A; Buda G; Lotti F; Liberatore C; Lazzaro A; Della Pepa R; Bertuglia G; Barbieri E; Conticello C; De Magistris C; De Paoli L; Bongarzoni V; Cafro AM; Mele A; Benvenuti P; Cerchione C; Botta C; Antonioli E; Sgherza N; et alii...

Bendamustine (B) in combination with rituximab (R) for patients with relapsed/resistant chronic lymphocytic leukemia (CLL): An Italian multicentre retrospective study in Haematologica

2010
ASL Vercelli

Iannitto E; Morabito F; Mancuso S; Gentile M; Augello A; Bongarzoni V; Cascavilla N; D'Arco A; Di Renzo N; Fazzi R; Ferrara F; Franco G; Gobbi M; Liardo E; Liberati AM; Marasca R; Montanini A; Mulè A; Musso M; Musto P; Pennese E; Piccin A; Rota Scalabrini D; Sciacca M; Visani G; Abbadessa V; Rigacci L;

Azacitidine for the treatment of lower risk myelodysplastic syndromes: A retrospective study of 74 patients enrolled in an Italian named patient program in Cancer

2010
ASL Vercelli

Musto P; Maurillo L; Spagnoli A; Gozzini A; Rivellini F; Lunghi M; Villani O; Aloe-Spiriti MA; Venditti A; Santini V; Leone G; Voso MT; D'Arco AM; Tatarelli C; Ferrero D; Gaidano G; Palumbo G; Di Raimondo F; Oliva E; Sanpaolo G; Tonso A; Santagostino A; Filardi N; Pollio B; Candoni A; Fili C; Russo D; Orciuolo E; Petrini M; et alii...